drugset / Trial / NCT03506841
Cerebrolysin and Neurodevelopment in Preterm Infants
RandomizedParallel-groupSingle-blindTreatment
Summary
The overall aim of the study is to assess the effect of Cerebrolysin on physical and mental development of preterm infants by Denver Scale II at different ages of 5, 7 and 12 months
Timeline
- Start
- 2016-06
- Primary completion
- 2019-06
- Completion
- 2019-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cerebrolysin | Peptide | 0.1 unknown | Other |